Market Reports

Multiplexed Diagnostics 2010
Published May 2010

The multiplexed diagnostics market has grown rapidly and generated sales of approximately $2.4 billon in 2009, but is now balanced on multiple tipping points. More>>

Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Published March 2010

There has been a significant transition in the diagnostic techniques created with increasing technological innovations. In the future, the focus will be on genetic study and disease predisposition, which will test patients' probability of acquiring a disease or a disorder, enabling precautionary steps. More>>

Multiplexed Diagnostics 2009 Market Report
Published March 2009

Multiplexed diagnostics are the long-awaited ascendance of ’omics into healthcare. The promise of multiple measurements to characterize complexity is finally being realized. More>>

Cancer Personalized Medicine 2008
Published July 2008

The Cancer Personalized Medicine marketplace represents the paradigm for personalized medicine market evolution and Select Biosciences focuses in this report on the various commercialized cancer predictor tests, their current status, traction in the marketplace, quantitative market opportunities, and the factors that are driving as well as challenging the expansion of this space. Personalized Medicine, especially as it relates to Cancer, is undergoing significant growth and this report focuses i More>>

Solving Drug Discovery with Metabolomics and Metabonomics
Published February 2005

There has been an 'omics' explosion. With the advent of genomics, proteomics, transcriptomics, there is also now metabolomics and metabonomics. These terms are the newest sibling to genomics and proteomics and are supposed to embody metabolic profiling. More>>